Cargando…
The clinical significance of epigenetic and RNAPII variabilities occurring in clear cell renal cell carcinoma as a potential prognostic marker
Patients diagnosed with clear cell renal cell carcinoma (ccRCC) have poor prognosis for recurrence and approximately 30–40% of them will later develop metastases. For this reason, the appropriate diagnosis and the more detailed molecular characterisation of the primary tumour, including its suscepti...
Autores principales: | Ördög, Nóra, Borsos, Barbara N, Majoros, Hajnalka, Ujfaludi, Zsuzsanna, Pankotai-Bodó, Gabriella, Bankó, Sarolta, Sükösd, Farkas, Kuthi, Levente, Pankotai, Tibor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018449/ https://www.ncbi.nlm.nih.gov/pubmed/35417813 http://dx.doi.org/10.1016/j.tranon.2022.101420 |
Ejemplares similares
-
Novel Diagnostic Value of Driver Gene Transcription Signatures to Characterise Clear Cell Renal Cell Carcinoma, ccRCC
por: Ujfaludi, Zsuzsanna, et al.
Publicado: (2022) -
The role of p53 in the DNA damage-related ubiquitylation of S2P RNAPII
por: Borsos, Barbara N., et al.
Publicado: (2022) -
BC-miR: Monitoring Breast Cancer-Related miRNA Profile in Blood Sera—A Prosperous Approach for Tumor Detection
por: Borsos, Barbara N., et al.
Publicado: (2022) -
Human p53 interacts with the elongating RNAPII complex and is required for the release of actinomycin D induced transcription blockage
por: Borsos, Barbara N., et al.
Publicado: (2017) -
Identifying Suitable Reference Gene Candidates for Quantification of DNA Damage-Induced Cellular Responses in Human U2OS Cell Culture System
por: Barta, Nikolett, et al.
Publicado: (2023)